MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Women's Health Initiative (WHI)

Phase 3
Completed
Conditions
Breast Neoplasms
Cardiovascular Diseases
Coronary Disease
Colonic Neoplasms
Heart Diseases
Myocardial Ischemia
Postmenopause
Bone Diseases
Osteoporosis
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000611

Aspirin-Myocardial Infarction Study (AMIS)

Phase 3
Completed
Conditions
Heart Diseases
Coronary Disease
Cardiovascular Diseases
Myocardial Infarction
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000491

Emory Angioplasty Versus Surgery Trial (EAST)

Phase 3
Completed
Conditions
Heart Diseases
Coronary Disease
Myocardial Ischemia
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000465

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

Phase 3
Completed
Conditions
Coronary Arteriosclerosis
Myocardial Ischemia
Postmenopause
Heart Diseases
Cardiovascular Diseases
Coronary Disease
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000605

Coronary Artery Bypass Graft (CABG) Patch Trial

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Myocardial Ischemia
Arrhythmia
Coronary Disease
Ventricular Arrhythmia
Death, Sudden, Cardiac
Myocardial Infarction
First Posted Date
1999-10-28
Last Posted Date
2016-11-06
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000540

Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)

Phase 3
Completed
Conditions
Lung Diseases
Pulmonary Embolism
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000566

Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)

Phase 3
Completed
Conditions
Hemoglobinopathies
Hematologic Diseases
Anemia, Sickle Cell
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000586

Antiarrhythmics Versus Implantable Defibrillators (AVID)

Phase 3
Completed
Conditions
Death, Sudden, Cardiac
Cardiovascular Diseases
Heart Diseases
Ventricular Fibrillation
Arrhythmia
Tachycardia, Ventricular
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000531

National Emphysema Treatment Trial (NETT)

Phase 3
Completed
Conditions
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease
Emphysema
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000606

Activity Counseling Trial (ACT)

Phase 3
Completed
Conditions
Heart Diseases
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000551
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy